Rate of major bleeding with ibrutinib versus bendamustine-rituximab in chronic lymphocytic leukemia: A population-based cohort study.

ABSTRACT:

SUBMITTER: Dhopeshwarkar N 

PROVIDER: S-EPMC10368070 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature